Prostate Cancer - Results from #26520

Prostate cancer: Localizing the cancer in patients with persistent negative biopsies - Abstract January 19, 2012

The role of Melancholia in prostate cancer patients' depression - Abstract January 19, 2012

Vitamin D with or without calcium supplementation for prevention of cancer and fractures: An updated meta-analysis for the U.S. Preventive Services Task Force - Abstract January 19, 2012

Effects of abiraterone acetate on androgen signaling in castrate-resistant prostate cancer in bone - Abstract January 19, 2012

Advanced prostate cancer: Reinforcing the strings between inflammation and the metastatic behavior - Abstract January 19, 2012

Serum insulin-like growth factors and mortality in localised and advanced clinically detected prostate cancer - Abstract January 19, 2012

Supervised Regularized Canonical Correlation Analysis: Integrating histologic and proteomic measurements for predicting biochemical recurrence following prostate surgery - Abstract January 19, 2012

Predicting erectile function outcome in men after radical prostatectomy for prostate cancer - Abstract January 19, 2012

Active surveillance for prostate cancer compared with immediate treatment: An economic analysis - Abstract January 18, 2012

Statin use and fatal prostate cancer: A matched case-control study - Abstract January 18, 2012

How does health literacy affect quality of life among men with newly diagnosed clinically localized prostate cancer?: Findings from the North Carolina-Louisiana Prostate Cancer Project (PCaP) - Abstract January 18, 2012

Evolution of endoscopic extraperitoneal radical prostatectomy (EERPE): Technique and outcome - Abstract January 18, 2012

Prediction of response to androgen deprivation therapy and castration resistance in primary metastatic prostate cancer - Abstract January 18, 2012

Value of enhanced transrectal ultrasound targeted biopsy for prostate cancer diagnosis: A retrospective data analysis - Abstract January 18, 2012

Impact of androgen deprivation on the lipid profile and atherogenic risk in prostate cancer patients - Abstract January 18, 2012

Second neoplasm after treatment of localized prostate cancer - Abstract January 18, 2012

Factors influencing treatment decision making and information preferences of prostate cancer patients on active surveillance - Abstract January 18, 2012

Sipuleucel-T (Provenge®) for castration-resistant prostate cancer - Abstract January 17, 2012

Long-term follow-up of patients undergoing percutaneous suprapubic tube drainage after robot-assisted radical prostatectomy (RARP) - Abstract January 17, 2012

Antioxidant therapy alleviates oxidative stress by androgen deprivation and prevents conversion from androgen dependent to castration resistant prostate cancer - Abstract January 17, 2012

Page 1327 of 1438